PRIA Logo™
HRES342119th Congress

Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes.

Sponsored By: Representative McGovern, James P. [D-MA-2]

Introduced

Summary

Recognition and support for people harmed by diethylstilbestrol (DES). This resolution would designate April 20–26, 2025 as DES Awareness Week, urge the Food and Drug Administration to apologize, and support restoring funding for the DES Follow-Up Study.

Show full summary
  • Families and survivors: The resolution would acknowledge that about 5 to 10 million pregnant women were prescribed DES and that in utero exposure has been linked to rare vaginal and cervical cancers called clear cell adenocarcinoma and to lasting fertility, pregnancy, physical, and mental health challenges.
  • Research and public health: The resolution would support restoring funding for the DES Follow-Up Study to help track long-term health effects and outcomes.
  • Federal accountability and awareness: The resolution would urge the FDA to issue a formal apology and use DES Awareness Week to raise public and clinical awareness of the drug's history and harms.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

McGovern, James P. [D-MA-2]

MA • D

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation